Advertisement
Short Communication| Volume 43, ISSUE 2, P209-214, March 2016

Transnasal administration of a combination of dexmedetomidine, midazolam and butorphanol produces deep sedation in New Zealand White rabbits

      Abstract

      Objective

      To study the sedative and cardiorespiratory effects of transnasal (TN) administration of a combination of dexmedetomidine (DEX), midazolam (MID) and butorphanol (BUT) administered through a nasal catheter to rabbits undergoing diagnostic procedures.

      Study design

      Descriptive cross-sectional experimental study.

      Animals

      Eight healthy New Zealand White rabbit does (12 ± 1 months old, 3.5 ± 0.3 kg).

      Methods

      DEX (0.1 mg kg−1), MID (2 mg kg−1) and BUT (0.4 mg kg−1) were mixed (DMB) in a syringe and applied to the rabbits’ nasopharyngeal mucosa after the accurate catheterization of one nostril. The onset, duration and quality of effects including analgesia were scored using a numeric rating scale of sedation for rabbits. Continuous monitoring of vital parameters was performed via clinical and multiparametric recording. Physiological variables were explored using repeated measures anova for parametric data or Friedman's test for non-parametric data. Tukey's or Dunn's post hoc multiple comparisons test was used depending on normality. The statistical significance was set at p < 0.05.

      Results

      Loss of the righting reflex, deep sedation and profound analgesia ensued simultaneously at 1.4 ± 1.1 minutes after DMB administration. These effects lasted 45 minutes before subsiding into moderate sedation, which lasted for an additional 25 minutes. Residual central nervous system impairment persisted up to 100 minutes. Blood pressure dropped progressively over time by 50%, whereas respiratory frequency decreased by 70%, consistent with moderate hypoxemia and hypercarbia.

      Conclusion and clinical relevance

      The TN route is a reliable and effective means for administration of DEX, MID and BUT to rabbits. The overall profound sedative effects and analgesic proprieties of the DMB combination can be selectively reversed depending on the needs of the procedure. Oxygen supplementation and careful monitoring are mandatory even in healthy subjects. The DMB protocol should be cautiously used in rabbits with cardiovascular or respiratory deficiencies.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eagleson JS
        • Platt SR
        • Elder Strong DL
        • et al.
        Bioavailability of a novel midazolam gel after intranasal administration in dogs.
        Am J Vet Res. 2012; 73: 6
        • Hedenqvist P
        • Orr HE
        • Roughan HE
        • et al.
        Anaesthesia with ketamine/medetomidine in the rabbit: influence of route of administration and the effect of combination with Butorphanol.
        Vet Anaesth Analg. 2002; 29: 14-19
        • Hedenqvist P
        • Edner A
        • Fahlman Å
        • et al.
        Continuous intravenous anaesthesia with sufentanil and midazolam in medetomidine premedicated New Zealand White rabbits.
        BMC Vet Res. 2013; 9: 21
        • Henke J
        • Astner S
        • Brill T
        • et al.
        Comparative study of three intramuscular anaesthetic combinations (medetomidine/ketamine, medetomidine/fentanyl/midazolam and xylazine/ketamine) in rabbits.
        Vet Anaesth Analg. 2005; 32: 261-270
        • Nishida T
        • Nishimura M
        • Kagawa K
        • et al.
        The effects of dexmedetomidine on the ventilatory response to hypercapnia in rabbits.
        Intensive Care Med. 2002; 28: 969-975
        • Portnoy LG
        • Hustead DR
        Pharmacokinetics of butorphanol tartrate in rabbits.
        Am J Vet Res. 1992; 53: 541-543
        • Raekallio M
        • Ansah OB
        • Kuusela E
        • et al.
        Some factors influencing the level of clinical sedation induced by medetomidine in rabbits.
        J Vet Pharmacol Ther. 2002; 25: 39-42
        • Robertson SA
        • Eberhart S
        Efficacy of the intranasal route for administration of anesthetic agents to adult rabbits.
        Lab Anim Sci. 1994; 44: 159-165
        • Schnellbacher RW
        • Hernandez SM
        • Tuberville TD
        • et al.
        The efficacy of intranasal administration of dexmedetomidine and ketamine to Yellow-Bellied Sliders (Trachemys scripta scripta).
        J Herpetol Med Surg. 2012; 22: 3-4
        • Schroeder CA
        • Smith LJ
        Respiratory rates and arterial blood-gas tensions in healthy rabbits given buprenorphine, butorphanol, midazolam, or their combinations.
        J Am Assoc Lab Anim Sci. 2011; 50: 205-211